![N-[4-(2-amino-1,3-thiazol-4-yl)phenyl]acetamide in PDB entry 8axp, assembly 2, side view.](https://www.ebi.ac.uk/pdbe/static/entry/8axp_entity_2_side_image-200x200.png "Monomeric assembly 2 of PDB entry <span class='highlight'>8axp</span> contains 1 copy of <span class='highlight'>N-[4-(2-amino-1,3-thiazol-4-yl)phenyl]acetamide</span>. Side view.")
![N-[4-(2-amino-1,3-thiazol-4-yl)phenyl]acetamide in PDB entry 8axp, assembly 2, top view.](https://www.ebi.ac.uk/pdbe/static/entry/8axp_entity_2_top_image-200x200.png "Monomeric assembly 2 of PDB entry <span class='highlight'>8axp</span> contains 1 copy of <span class='highlight'>N-[4-(2-amino-1,3-thiazol-4-yl)phenyl]acetamide</span>. Top view.")
Environment details NEW
O0J 201 bound to chain A
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.